P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment

详细信息    查看全文

• 作者：Donald E. Schmechel ; Gary Gerard ; Nick G. Vatakis ; Linda Harper ; Joel S. Ross ; Mohammed Bari ; David Walling ; Mary Stedman ; Jaron L. Winston ; Bruce Morimoto ; Julian R. Keith
• 刊名：Alzheimer's Dementia
• 出版年：2008
• 出版时间：July 2008
• 年：2008
• 卷：4
• 期：4, Supplement 1
• 页码：T483
• 全文大小：61 K

文摘